OpenVSafe by OpenVAERS
Search V-safe

YX9-16536-69043

3 vaccinations 5 coded responses 35 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
921 / CA
Registered
2021-01-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-13
    Registered in v-safe
  2. 2021-01-13
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-13
    Survey response — day 0, dose 1
    MedDRA: Headache — Feeling: Good · Headache
    Free text: Headache may not be vaccine related.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  6. 2021-01-15
  7. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-27
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-03
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  16. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-02-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-24
    Survey response — day 21, dose 2
    MedDRA: Headache, Pyrexia — Feeling: Good · Be unable to do your normal daily activities
    Free text: 100.9° fever and headache yesterday, no other symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-05
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-08-04
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Night sweats, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: low grade recurring fever, severe fatigue, night sweats
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-04
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-08-10
  28. 2021-12-15
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  30. 2021-12-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Abdominal pain
    Adult check-in
  31. 2021-12-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  32. 2021-12-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-12-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-12-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-12-22
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-12-29
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-01-05
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-01-12
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-19
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-01-26
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-03-17
    Survey response — 3 months, dose 3
    MedDRA: Influenza — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Flu symptoms since 3/14, slowly improving
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-06-15
    Survey response — 6 months, dose 3
    MedDRA: Pregnancy, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Pregnancy, positive COVID-19 test
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-06-15
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  44. 2022-06-17
  45. 2022-06-17

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Pfizer-BioNTech
22021-02-03Pfizer-BioNTech
32021-12-15Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-15 priority 2/3
2021-08-04 Unsuccessful
2022-06-15 Unsuccessful

Free text

Release 1 — day 0, dose 1

2021-01-13

Systemic reaction (other): Headache may not be vaccine related.

Release 4 — day 21, dose 2

2021-02-24

Symptoms: 100.9° fever and headache yesterday, no other symptoms

Release 9 — 6 months, dose 2

2021-08-04

Symptoms: low grade recurring fever, severe fatigue, night sweats

Release 11 — 3 months, dose 3

2022-03-17

Symptoms: Flu symptoms since 3/14, slowly improving

Release 12 — 6 months, dose 3

2022-06-15

Symptoms: Pregnancy, positive COVID-19 test

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue ✓ · ✓
SDHeadache ✓ ✓ ✓
SDInfluenza · · ✓
SDNight sweats ✓ · ✓
SDPregnancy · · ✓
SDPyrexia ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SROHeadache ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release